Ventricular Assist Devices

Ventricular assist device Jarvik 2000 has made significant progress in artificial heart since its predecessor Jarvik-7. Jarvik 2000 is a ventricular assist device. Ventricular assist device (VAD) is an invasive alternative to artificial heart transplantation. They are designed not to replace the heart but to help the heart draw out blood. These devices are implanted in the body and deliver blood through the aorta, thereby reducing their weakened ventricle of their normal workload.

Left ventricular assist device (LVAD) is a mechanical pump implanted in heart failure patients. It helps the left lower chamber (left ventricle) of the heart to draw blood from the ventricle into the aorta and other parts of the body. This is why it is called a left ventricular assist device. The pump unit is placed in the chest. It is implanted by the surgeon at the apex of the heart where it receives blood. The tube then sends this blood from the device to the aorta (the aorta that transports the blood from the heart to the rest of the body). The aorta functions by pumping blood from a continuous flow from the left ventricle to the aorta.

A ventricular assist device (VAD) is a pump connected to the heart to aid a weakened ventricle to pump blood into the body. VAD can be used as a final treatment option for advanced HF-rEF patients or as a "heart transplant bridge". In other words, the device is in the correct position until heart transplant is possible. There are various kinds of VAD. There is only one type shown here

Over 20 years, the Cleveland Clinic 's Cleveland Heart Failure Center surgeon has successfully used a ventricular assist device (VAD) as a bridge graft for patients waiting for a heart transplant. The Cleveland Clinic has one of America's most experienced VAD programs. Cleveland Clinic can use FDA approved ventricular assist device and new research equipment

Advances in research introduce new life support technology to clinical. For example, many patients have life support devices such as cardiac pacemakers, implantable defibrillators, and ventricular assist devices. The physician will inevitably encounter a patient with a terminal disease (eg, cancer) whose fundamental disease is no longer being effectively treated by the device or the device can not be treated . In anticipation of natural death, the patient or its agent may request discontinuation of treatment provided by these devices. In these cases, subsequent mortality is due to the underlying heart disease or other comorbidities (49, 50). Doctors should respect these demands. However, in the absence of a clear boundary between suicide by the doctor and suicide by the doctor, or if there is confusion between the two, some doctors cease using these treatments as deliberate homicide and like that You may think that you refuse to execute a request.